<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Four epidemiologic forms of <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> have been described, <z:hpo ids='HP_0000001'>all</z:hpo> of which are associated with the human herpesvirus-8 </plain></SENT>
<SENT sid="1" pm="."><plain>In western countries, human herpesvirus-8 is more prevalent in homosexual men than in the general population, and anecdotal cases of <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> in HIV-negative homosexual men have been reported </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: We included HIV-negative homosexual and bisexual male patients with histologically proven <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> in a retrospective study </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical data were collected using a standardized form </plain></SENT>
<SENT sid="4" pm="."><plain>Risk factors for <z:e sem="disease" ids="C1512508" disease_type="Disease or Syndrome" abbrv="">human herpesvirus-8 infection</z:e> and for the development of <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> were systematically recorded </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Between 1995 and 2007, 28 men met the defined inclusion criteria </plain></SENT>
<SENT sid="6" pm="."><plain>Mean age at first symptoms of <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> was 53 years </plain></SENT>
<SENT sid="7" pm="."><plain>Clinical presentation resembled classical <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo>, with limited disease in most patients </plain></SENT>
<SENT sid="8" pm="."><plain>No cellular or humoral <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> was observed </plain></SENT>
<SENT sid="9" pm="."><plain>Serologic tests for human herpesvirus-8 (latent immunofluorescence assay) were positive in 88% of patients, and only two patients displayed human herpesvirus-8 viremia at the time of <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> diagnosis </plain></SENT>
<SENT sid="10" pm="."><plain>Three patients developed <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> (<z:e sem="disease" ids="C0017531" disease_type="Disease or Syndrome" abbrv="GLNH|AFLH">Castleman disease</z:e>, follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) </plain></SENT>
<SENT sid="11" pm="."><plain>In this population, alpha-interferon was well tolerated and gave a complete response, but most patients require only local treatment, if any </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> may develop in homosexual or bisexual men without <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>This type of <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> has clinical features in common with classical <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> but occurs in younger patients </plain></SENT>
<SENT sid="14" pm="."><plain>Its prognosis is good, as <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> is generally limited, but clinicians should be aware of the association with <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative diseases</z:e>, which may affect prognosis </plain></SENT>
</text></document>